<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-04-01" modified="2018-01-31" version="204">
<accession>P16234</accession>
<accession>B2RE69</accession>
<accession>E9PBH0</accession>
<accession>Q6P4H5</accession>
<accession>Q96KZ7</accession>
<accession>Q9UD28</accession>
<name>PGFRA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Platelet-derived growth factor receptor alpha</fullName>
<shortName>PDGF-R-alpha</shortName>
<shortName>PDGFR-alpha</shortName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Alpha platelet-derived growth factor receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Alpha-type platelet-derived growth factor receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>CD140 antigen-like family member A</fullName>
</alternativeName>
<alternativeName>
<fullName>CD140a antigen</fullName>
</alternativeName>
<alternativeName>
<fullName>Platelet-derived growth factor alpha receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Platelet-derived growth factor receptor 2</fullName>
<shortName>PDGFR-2</shortName>
</alternativeName>
<cdAntigenName>CD140a</cdAntigenName>
</protein>
<gene>
<name type="primary">PDGFRA</name>
<name type="synonym">PDGFR2</name>
<name type="synonym">RHEPDGFRA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="4917" last="4921">
<title>cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor.</title>
<authorList>
<person name="Claesson-Welsh L."/>
<person name="Eriksson A."/>
<person name="Westermark B."/>
<person name="Heldin C.H."/>
</authorList>
<dbReference type="PubMed" id="2544881"/>
<dbReference type="DOI" id="10.1073/pnas.86.13.4917"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH PDGFA AND PDGFB</scope>
<source>
<tissue>Foreskin</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="Science" volume="243" first="800" last="804">
<title>Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes.</title>
<authorList>
<person name="Matsui T."/>
<person name="Heidaran M."/>
<person name="Miki T."/>
<person name="Popescu N."/>
<person name="la Rochelle W."/>
<person name="Kraus M."/>
<person name="Pierce J."/>
<person name="Aaronson S."/>
</authorList>
<dbReference type="PubMed" id="2536956"/>
<dbReference type="DOI" id="10.1126/science.2536956"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH PDGFA AND PDGFB</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="Genomics" volume="30" first="224" last="232">
<title>Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA.</title>
<authorList>
<person name="Kawagishi J."/>
<person name="Ku T."/>
</authorList>
<dbReference type="PubMed" id="8586421"/>
<dbReference type="DOI" id="10.1006/geno.1995.9883"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT PRO-478</scope>
<source>
<tissue>Lung</tissue>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3)</scope>
<scope>VARIANT PRO-478</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="7830" last="7835">
<title>Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome.</title>
<authorList>
<person name="Griffin J.H."/>
<person name="Leung J."/>
<person name="Bruner R.J."/>
<person name="Caligiuri M.A."/>
<person name="Briesewitz R."/>
</authorList>
<dbReference type="PubMed" id="12808148"/>
<dbReference type="DOI" id="10.1073/pnas.0932698100"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 579-1089</scope>
<scope>DISEASE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY OF FIP1L1-PDGFRA FUSION PROTEIN</scope>
<source>
<tissue>Eosinophil</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1995" name="Int. J. Cancer" volume="60" first="791" last="797">
<title>Receptor tyrosine kinases expressed in metastatic colon cancer.</title>
<authorList>
<person name="Craven R.J."/>
<person name="Xu L.H."/>
<person name="Weiner T.M."/>
<person name="Fridell Y.-W."/>
<person name="Dent G.A."/>
<person name="Srivastava S."/>
<person name="Varnum B."/>
<person name="Liu E.T."/>
<person name="Cance W.G."/>
</authorList>
<dbReference type="PubMed" id="7896447"/>
<dbReference type="DOI" id="10.1002/ijc.2910600611"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 823-876</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Colon tumor</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="8314" last="8318">
<title>Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways.</title>
<authorList>
<person name="Matsui T."/>
<person name="Pierce J.H."/>
<person name="Fleming T.P."/>
<person name="Greenberger J.S."/>
<person name="LaRochelle W.J."/>
<person name="Ruggiero M."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="2554309"/>
<dbReference type="DOI" id="10.1073/pnas.86.21.8314"/>
</citation>
<scope>FUNCTION AS PDGFA AND PDGFB RECEPTOR IN CELL PROLIFERATION AND CHEMOTAXIS</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1990" name="Science" volume="250" first="979" last="982">
<title>Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors.</title>
<authorList>
<person name="Anderson D."/>
<person name="Koch C.A."/>
<person name="Grey L."/>
<person name="Ellis C."/>
<person name="Moran M.F."/>
<person name="Pawson T."/>
</authorList>
<dbReference type="PubMed" id="2173144"/>
<dbReference type="DOI" id="10.1126/science.2173144"/>
</citation>
<scope>INTERACTION WITH PLCG1 AND SRC</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="8987" last="8992">
<title>Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation.</title>
<authorList>
<person name="Kelly J.D."/>
<person name="Haldeman B.A."/>
<person name="Grant F.J."/>
<person name="Murray M.J."/>
<person name="Seifert R.A."/>
<person name="Bowen-Pope D.F."/>
<person name="Cooper J.A."/>
<person name="Kazlauskas A."/>
</authorList>
<dbReference type="PubMed" id="1709159"/>
</citation>
<scope>INTERACTION WITH PDGFRA; PDGFA AND PDGFB</scope>
<scope>FUNCTION AS RECEPTOR FOR PDGFA AND PDGFB</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="3780" last="3785">
<title>Tyrosine mutations within the alpha platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction.</title>
<authorList>
<person name="Yu J.C."/>
<person name="Heidaran M.A."/>
<person name="Pierce J.H."/>
<person name="Gutkind J.S."/>
<person name="Lombardi D."/>
<person name="Ruggiero M."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="1646396"/>
<dbReference type="DOI" id="10.1128/MCB.11.7.3780"/>
</citation>
<scope>FUNCTION AS PDGFB RECEPTOR IN CHEMOTAXIS; CELL PROLIFERATION; PHOSPHORYLATION OF PLCG1; ACTIVATION OF PHOSPHATIDYLINOSITOL 3-KINASE AND REGULATION OF PHOSPHATIDYLINOSITOL METABOLISM</scope>
<scope>INTERACTION WITH PIK3R</scope>
<scope>PHOSPHORYLATION AT TYR-731 AND TYR-742</scope>
<scope>MUTAGENESIS OF TYR-731 AND TYR-742</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="3625" last="3631">
<title>Mechanism of platelet-derived growth factor (PDGF) AA, AB, and BB binding to alpha and beta PDGF receptor.</title>
<authorList>
<person name="Fretto L.J."/>
<person name="Snape A.J."/>
<person name="Tomlinson J.E."/>
<person name="Seroogy J.J."/>
<person name="Wolf D.L."/>
<person name="LaRochelle W.J."/>
<person name="Giese N.A."/>
</authorList>
<dbReference type="PubMed" id="7679113"/>
</citation>
<scope>INTERACTION WITH PDGFA AND PDGFB</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="13874" last="13879">
<title>Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor.</title>
<authorList>
<person name="Vassbotn F.S."/>
<person name="Havnen O.K."/>
<person name="Heldin C.H."/>
<person name="Holmsen H."/>
</authorList>
<dbReference type="PubMed" id="8188664"/>
</citation>
<scope>FUNCTION AS PDGFA RECEPTOR IN REGULATION OF PLATELET ACTIVATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="7773" last="7781">
<title>Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors.</title>
<authorList>
<person name="Eriksson A."/>
<person name="Naanberg E."/>
<person name="Roennstrand L."/>
<person name="Engstroem U."/>
<person name="Hellman U."/>
<person name="Rupp E."/>
<person name="Carpenter G."/>
<person name="Heldin C.H."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="7535778"/>
<dbReference type="DOI" id="10.1074/jbc.270.13.7773"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-988 AND TYR-1018</scope>
<scope>INTERACTION WITH PLCG1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1996" name="Am. J. Physiol." volume="271" first="L93" last="L99">
<title>Maximal PDGF-induced lung fibroblast chemotaxis requires PDGF receptor-alpha.</title>
<authorList>
<person name="Osornio-Vargas A.R."/>
<person name="Lindroos P.M."/>
<person name="Coin P.G."/>
<person name="Badgett A."/>
<person name="Hernandez-Rodriguez N.A."/>
<person name="Bonner J.C."/>
</authorList>
<dbReference type="PubMed" id="8760137"/>
</citation>
<scope>FUNCTION IN PROMOTING CHEMOTAXIS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="5101" last="5111">
<title>Structural determinants in the platelet-derived growth factor alpha-receptor implicated in modulation of chemotaxis.</title>
<authorList>
<person name="Yokote K."/>
<person name="Mori S."/>
<person name="Siegbahn A."/>
<person name="Ronnstrand L."/>
<person name="Wernstedt C."/>
<person name="Heldin C.H."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="8617789"/>
<dbReference type="DOI" id="10.1074/jbc.271.9.5101"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-768</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="30942" last="30949">
<title>Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors.</title>
<authorList>
<person name="Yokote K."/>
<person name="Margolis B."/>
<person name="Heldin C.H."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="8940081"/>
<dbReference type="DOI" id="10.1074/jbc.271.48.30942"/>
</citation>
<scope>INTERACTION WITH GRB7 AND PIK3R1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="6926" last="6936">
<title>Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation.</title>
<authorList>
<person name="Bazenet C.E."/>
<person name="Gelderloos J.A."/>
<person name="Kazlauskas A."/>
</authorList>
<dbReference type="PubMed" id="8943348"/>
<dbReference type="DOI" id="10.1128/MCB.16.12.6926"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PTPN11; ACTIVATION OF HRAS AND REGULATION OF CELL PROLIFERATION</scope>
<scope>PHOSPHORYLATION AT TYR-720</scope>
<scope>INTERACTION WITH GRB2; PTPN11; PLCG1 AND PIK3R1</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF TYR-720</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="270" first="28" last="33">
<title>Differential interaction of CrkII adaptor protein with platelet-derived growth factor alpha- and beta-receptors is determined by its internal tyrosine phosphorylation.</title>
<authorList>
<person name="Matsumoto T."/>
<person name="Yokote K."/>
<person name="Take A."/>
<person name="Takemoto M."/>
<person name="Asaumi S."/>
<person name="Hashimoto Y."/>
<person name="Matsuda M."/>
<person name="Saito Y."/>
<person name="Mori S."/>
</authorList>
<dbReference type="PubMed" id="10733900"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.2374"/>
</citation>
<scope>INTERACTION WITH CRK</scope>
<scope>PHOSPHORYLATION AT TYR-762</scope>
<scope>MUTAGENESIS OF TYR-762</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="278" first="537" last="543">
<title>Shf, a Shb-like adapter protein, is involved in PDGF-alpha-receptor regulation of apoptosis.</title>
<authorList>
<person name="Lindholm C.K."/>
<person name="Frantz J.D."/>
<person name="Shoelson S.E."/>
<person name="Welsh M."/>
</authorList>
<dbReference type="PubMed" id="11095946"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.3847"/>
</citation>
<scope>INTERACTION WITH SHF</scope>
<scope>PHOSPHORYLATION AT TYR-720</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2000" name="Biochem. J." volume="350" first="469" last="475">
<title>Platelet-derived-growth-factor-induced signalling in human platelets: phosphoinositide-3-kinase-dependent inhibition of platelet activation.</title>
<authorList>
<person name="Selheim F."/>
<person name="Fukami M.H."/>
<person name="Holmsen H."/>
<person name="Vassbotn F.S."/>
</authorList>
<dbReference type="PubMed" id="10947961"/>
<dbReference type="DOI" id="10.1042/bj3500469"/>
</citation>
<scope>FUNCTION IN PLATELET ACTIVATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="9620" last="9627">
<title>Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progression.</title>
<authorList>
<person name="Rosenkranz S."/>
<person name="Ikuno Y."/>
<person name="Leong F.L."/>
<person name="Klinghoffer R.A."/>
<person name="Miyake S."/>
<person name="Band H."/>
<person name="Kazlauskas A."/>
</authorList>
<dbReference type="PubMed" id="10734113"/>
<dbReference type="DOI" id="10.1074/jbc.275.13.9620"/>
</citation>
<scope>FUNCTION IN ACTIVATION OF MAPK1/ERK2 AND/OR MAPK3/ERK1</scope>
<scope>DEGRADATION</scope>
<scope>PHOSPHORYLATION AT TYR-572 AND TYR-574</scope>
<scope>MUTAGENESIS OF TYR-572 AND TYR-574</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="27406" last="27414">
<title>Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor.</title>
<authorList>
<person name="Gilbertson D.G."/>
<person name="Duff M.E."/>
<person name="West J.W."/>
<person name="Kelly J.D."/>
<person name="Sheppard P.O."/>
<person name="Hofstrand P.D."/>
<person name="Gao Z."/>
<person name="Shoemaker K."/>
<person name="Bukowski T.R."/>
<person name="Moore M."/>
<person name="Feldhaus A.L."/>
<person name="Humes J.M."/>
<person name="Palmer T.E."/>
<person name="Hart C.E."/>
</authorList>
<dbReference type="PubMed" id="11297552"/>
<dbReference type="DOI" id="10.1074/jbc.M101056200"/>
</citation>
<scope>FUNCTION AS A RECEPTOR FOR PDGFC</scope>
<scope>INTERACTION WITH PDGFC</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="Exp. Cell Res." volume="291" first="426" last="434">
<title>The role of c-Src in platelet-derived growth factor alpha receptor internalization.</title>
<authorList>
<person name="Avrov K."/>
<person name="Kazlauskas A."/>
</authorList>
<dbReference type="PubMed" id="14644164"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2003.08.001"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SRC</scope>
<scope>MUTAGENESIS OF TYR-572 AND TYR-574</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="N. Engl. J. Med." volume="348" first="1201" last="1214">
<title>A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.</title>
<authorList>
<person name="Cools J."/>
<person name="DeAngelo D.J."/>
<person name="Gotlib J."/>
<person name="Stover E.H."/>
<person name="Legare R.D."/>
<person name="Cortes J."/>
<person name="Kutok J."/>
<person name="Clark J."/>
<person name="Galinsky I."/>
<person name="Griffin J.D."/>
<person name="Cross N.C."/>
<person name="Tefferi A."/>
<person name="Malone J."/>
<person name="Alam R."/>
<person name="Schrier S.L."/>
<person name="Schmid J."/>
<person name="Rose M."/>
<person name="Vandenberghe P."/>
<person name="Verhoef G."/>
<person name="Boogaerts M."/>
<person name="Wlodarska I."/>
<person name="Kantarjian H."/>
<person name="Marynen P."/>
<person name="Coutre S.E."/>
<person name="Stone R."/>
<person name="Gilliland D.G."/>
</authorList>
<dbReference type="PubMed" id="12660384"/>
<dbReference type="DOI" id="10.1056/NEJMoa025217"/>
</citation>
<scope>INVOLVEMENT IN HES</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="Science" volume="299" first="708" last="710">
<title>PDGFRA activating mutations in gastrointestinal stromal tumors.</title>
<authorList>
<person name="Heinrich M.C."/>
<person name="Corless C.L."/>
<person name="Duensing A."/>
<person name="McGreevey L."/>
<person name="Chen C.J."/>
<person name="Joseph N."/>
<person name="Singer S."/>
<person name="Griffith D.J."/>
<person name="Haley A."/>
<person name="Town A."/>
<person name="Demetri G.D."/>
<person name="Fletcher C.D."/>
<person name="Fletcher J.A."/>
</authorList>
<dbReference type="PubMed" id="12522257"/>
<dbReference type="DOI" id="10.1126/science.1079666"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF AKT1; MAP KINASES; STAT1 AND STAT3</scope>
<scope>INVOLVEMENT IN GIST</scope>
<scope>VARIANTS ASP-561; VAL-842; 842-ASP--HIS-845 DEL AND 845-HIS--PRO-448 DEL</scope>
<scope>CHARACTERIZATION OF VARIANTS ASP-561; VAL-842; 842-ASP--HIS-845 DEL AND 845-HIS--PRO-448 DEL</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="J. Clin. Oncol." volume="23" first="5357" last="5364">
<title>PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.</title>
<authorList>
<person name="Corless C.L."/>
<person name="Schroeder A."/>
<person name="Griffith D."/>
<person name="Town A."/>
<person name="McGreevey L."/>
<person name="Harrell P."/>
<person name="Shiraga S."/>
<person name="Bainbridge T."/>
<person name="Morich J."/>
<person name="Heinrich M.C."/>
</authorList>
<dbReference type="PubMed" id="15928335"/>
<dbReference type="DOI" id="10.1200/JCO.2005.14.068"/>
</citation>
<scope>INVOLVEMENT IN GIST</scope>
<scope>VARIANTS ASP-561; LYS-659; TYR-842; VAL-842; 842-ASP--HIS-845 DEL 845-HIS--PRO-448 DEL AND CYS-849</scope>
<scope>CHARACTERIZATION OF VARIANTS ASP-561; LYS-659; TYR-842; VAL-842; 842-ASP--HIS-845 DEL 845-HIS--PRO-448 DEL AND CYS-849</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="FEBS Lett." volume="580" first="6769" last="6776">
<title>PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinases.</title>
<authorList>
<person name="Vantler M."/>
<person name="Huntgeburth M."/>
<person name="Caglayan E."/>
<person name="Ten Freyhaus H."/>
<person name="Schnabel P."/>
<person name="Rosenkranz S."/>
</authorList>
<dbReference type="PubMed" id="17141222"/>
<dbReference type="DOI" id="10.1016/j.febslet.2006.11.034"/>
</citation>
<scope>FUNCTION IN CELL SURVIVAL</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="Mol. Cancer Ther." volume="6" first="1932" last="1941">
<title>Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer.</title>
<authorList>
<person name="Stock P."/>
<person name="Monga D."/>
<person name="Tan X."/>
<person name="Micsenyi A."/>
<person name="Loizos N."/>
<person name="Monga S.P."/>
</authorList>
<dbReference type="PubMed" id="17604334"/>
<dbReference type="DOI" id="10.1158/1535-7163.MCT-06-0720"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-754</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="J. Virol." volume="84" first="10026" last="10037">
<title>The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry.</title>
<authorList>
<person name="Feire A.L."/>
<person name="Roy R.M."/>
<person name="Manley K."/>
<person name="Compton T."/>
</authorList>
<dbReference type="PubMed" id="20660204"/>
<dbReference type="DOI" id="10.1128/JVI.00710-10"/>
</citation>
<scope>INTERACTION WITH HHV-5 GB</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="Blood" volume="117" first="2935" last="2943">
<title>Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease.</title>
<authorList>
<person name="Elling C."/>
<person name="Erben P."/>
<person name="Walz C."/>
<person name="Frickenhaus M."/>
<person name="Schemionek M."/>
<person name="Stehling M."/>
<person name="Serve H."/>
<person name="Cross N.C."/>
<person name="Hochhaus A."/>
<person name="Hofmann W.K."/>
<person name="Berdel W.E."/>
<person name="Muller-Tidow C."/>
<person name="Reiter A."/>
<person name="Koschmieder S."/>
</authorList>
<dbReference type="PubMed" id="21224473"/>
<dbReference type="DOI" id="10.1182/blood-2010-05-286757"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF STAT 5A AND/OR STAT5B</scope>
<scope>ROLE IN HYPEREOSINOPHILIC SYNDROME</scope>
<scope>VARIANTS GLY-481; PRO-507; MET-562; ARG-570; GLN-650; SER-659; PRO-705; GLY-748 AND SER-849</scope>
<scope>CHARACTERIZATION OF VARIANTS GLY-481; PRO-507; MET-562; ARG-570; GLN-650; SER-659; PRO-705; GLY-748 AND SER-849</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="24443" last="24450">
<title>The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination.</title>
<authorList>
<person name="Severe N."/>
<person name="Miraoui H."/>
<person name="Marie P.J."/>
</authorList>
<dbReference type="PubMed" id="21596750"/>
<dbReference type="DOI" id="10.1074/jbc.M110.197525"/>
</citation>
<scope>FUNCTION IN CELL DIFFERENTIATION</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="Oncogene" volume="30" first="933" last="943">
<title>The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro.</title>
<authorList>
<person name="von Bubnoff N."/>
<person name="Gorantla S.P."/>
<person name="Engh R.A."/>
<person name="Oliveira T.M."/>
<person name="Thone S."/>
<person name="Aberg E."/>
<person name="Peschel C."/>
<person name="Duyster J."/>
</authorList>
<dbReference type="PubMed" id="20972453"/>
<dbReference type="DOI" id="10.1038/onc.2010.476"/>
</citation>
<scope>ROLE IN DISEASE</scope>
<scope>CHARACTERIZATION OF VARIANT VAL-842</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1998" name="Biochim. Biophys. Acta" volume="1378" first="F79" last="113">
<title>Signal transduction via platelet-derived growth factor receptors.</title>
<authorList>
<person name="Heldin C.H."/>
<person name="Ostman A."/>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="9739761"/>
<dbReference type="DOI" id="10.1016/S0304-419X(98)00015-8"/>
</citation>
<scope>REVIEW ON SIGNALING AND AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="Cytokine Growth Factor Rev." volume="15" first="275" last="286">
<title>PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma.</title>
<authorList>
<person name="Ostman A."/>
</authorList>
<dbReference type="PubMed" id="15207817"/>
<dbReference type="DOI" id="10.1016/j.cytogfr.2004.03.002"/>
</citation>
<scope>REVIEW ON ROLE IN DISEASE AND ENZYME REGULATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Adv. Cancer Res." volume="97" first="247" last="274">
<title>PDGF receptors as targets in tumor treatment.</title>
<authorList>
<person name="Ostman A."/>
<person name="Heldin C.H."/>
</authorList>
<dbReference type="PubMed" id="17419949"/>
<dbReference type="DOI" id="10.1016/S0065-230X(06)97011-0"/>
</citation>
<scope>REVIEW ON ROLE IN DISEASE AND ENZYME REGULATION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Genes Dev." volume="22" first="1276" last="1312">
<title>Role of platelet-derived growth factors in physiology and medicine.</title>
<authorList>
<person name="Andrae J."/>
<person name="Gallini R."/>
<person name="Betsholtz C."/>
</authorList>
<dbReference type="PubMed" id="18483217"/>
<dbReference type="DOI" id="10.1101/gad.1653708"/>
</citation>
<scope>REVIEW ON FUNCTION IN DEVELOPMENT AND DISEASE; LIGANDS AND SIGNALING PATHWAYS</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="18973" last="18978">
<title>Structural determinants of the Na+/H+ exchanger regulatory factor interaction with the beta 2 adrenergic and platelet-derived growth factor receptors.</title>
<authorList>
<person name="Karthikeyan S."/>
<person name="Leung T."/>
<person name="Ladias J.A.A."/>
</authorList>
<dbReference type="PubMed" id="11882663"/>
<dbReference type="DOI" id="10.1074/jbc.M201507200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1185-1189 IN COMPLEX WITH SLC9A3R1 AND PDGFRB</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ASP-79; ASP-426; PRO-478; CYS-764; ARG-829; LYS-996 AND ASN-1071</scope>
</reference>
<comment type="function">
<text evidence="9 10 12 14 20 21 22 26 27 28 32 36 38 40">Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands - homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor.</text>
</comment>
<comment type="catalytic activity">
<text evidence="7">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="19 26 27">Present in an inactive conformation in the absence of bound ligand. Binding of PDGFA and/or PDGFB leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by imatinib, nilotinib and sorafenib.</text>
</comment>
<comment type="subunit">
<text evidence="3 8 11 12 13 16 20 21 25 29 30 31 33 34 39 40">Interacts with homodimeric PDGFA, PDGFB and PDGFC, and with heterodimers formed by PDGFA and PDGFB. Monomer in the absence of bound ligand. Interaction with dimeric PDGFA, PDGFB and/or PDGFC leads to receptor dimerization, where both PDGFRA homodimers and heterodimers with PDGFRB are observed. Interacts (tyrosine phosphorylated) with SHB (via SH2 domain) (By similarity). Interacts (tyrosine phosphorylated) with SHF (via SH2 domain). Interacts (tyrosine phosphorylated) with SRC (via SH2 domain). Interacts (tyrosine phosphorylated) with PIK3R1. Interacts (tyrosine phosphorylated) with PLCG1 (via SH2 domain). Interacts (tyrosine phosphorylated) with CRK, GRB2 and GRB7. Interacts with human cytomegalovirus/HHV-5 envelop glycoprotein B/gB.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2861522"/>
<interactant intactId="EBI-749265">
<id>Q8N6L0</id>
<label>CCDC155</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2861522"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2861522"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2861522"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2861522"/>
<interactant intactId="EBI-2881386">
<id>P04085</id>
<label>PDGFA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2861522"/>
<interactant intactId="EBI-1554925">
<id>P01127</id>
<label>PDGFB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2861522"/>
<interactant intactId="EBI-8833587">
<id>Q9NRA1</id>
<label>PDGFC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15499330"/>
<interactant intactId="EBI-15499301">
<id>Q9NRA1-1</id>
<label>PDGFC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15499330"/>
<interactant intactId="EBI-15722055">
<id>A8T7D5</id>
<label>UL55</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="16 32 36">Cell membrane</location>
<topology evidence="16 32 36">Single-pass type I membrane protein</topology>
</subcellularLocation>
<text>The activated receptor is rapidly internalized and degraded.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P16234-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P16234-2</id>
<name>2</name>
<sequence type="described" ref="VSP_007833 VSP_007834"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P16234-3</id>
<name>3</name>
<sequence type="described" ref="VSP_042015 VSP_042016"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="30 35 36">Detected in platelets (at protein level). Widely expressed. Detected in brain, fibroblasts, smooth muscle, heart, and embryo. Expressed in primary and metastatic colon tumors and in normal colon tissue.</text>
</comment>
<comment type="PTM">
<text>N-glycosylated.</text>
</comment>
<comment type="PTM">
<text evidence="43">Ubiquitinated, leading to its degradation.</text>
</comment>
<comment type="PTM">
<text evidence="8 9 11 20 33 40">Autophosphorylated on tyrosine residues upon ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation at Tyr-731 and Tyr-742 is important for interaction with PIK3R1. Phosphorylation at Tyr-720 and Tyr-754 is important for interaction with PTPN11. Phosphorylation at Tyr-762 is important for interaction with CRK. Phosphorylation at Tyr-572 and Tyr-574 is important for interaction with SRC and SRC family members. Phosphorylation at Tyr-988 and Tyr-1018 is important for interaction with PLCG1.</text>
</comment>
<comment type="disease">
<text evidence="15">A chromosomal aberration involving PDGFRA is found in some cases of hypereosinophilic syndrome. Interstitial chromosomal deletion del(4)(q12q12) causes the fusion of FIP1L1 and PDGFRA (FIP1L1-PDGFRA). Mutations that cause overexpression and/or constitutive activation of PDGFRA may be a cause of hypereosinophilic syndrome.</text>
</comment>
<comment type="disease" evidence="14 19">
<disease id="DI-01646">
<name>Gastrointestinal stromal tumor</name>
<acronym>GIST</acronym>
<description>Common mesenchymal neoplasms arising in the gastrointestinal tract, most often in the stomach. They are histologically, immunohistochemically, and genetically different from typical leiomyomas, leiomyosarcomas, and schwannomas. Most GISTs are composed of a fairly uniform population of spindle-shaped cells. Some tumors are dominated by epithelioid cells or contain a mixture of spindle and epithelioid morphologies. Primary GISTs in the gastrointestinal tract commonly metastasize in the omentum and mesenteries, often as multiple nodules. However, primary tumors may also occur outside of the gastrointestinal tract, in other intra-abdominal locations, especially in the omentum and mesentery.</description>
<dbReference type="MIM" id="606764"/>
</disease>
<text evidence="14">The gene represented in this entry may be involved in disease pathogenesis. Mutations causing PDGFRA constitutive activation have been found in gastrointestinal stromal tumors lacking KIT mutations (PubMed:12522257).</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.</text>
</comment>
<comment type="sequence caution" evidence="42">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAP69563" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="M22734">
<property type="protein sequence ID" value="AAA60048.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M21574">
<property type="protein sequence ID" value="AAA96715.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D50017">
<property type="protein sequence ID" value="BAA08742.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK316578">
<property type="protein sequence ID" value="BAG38166.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC098587">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC138779">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015186">
<property type="protein sequence ID" value="AAH15186.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC063414">
<property type="protein sequence ID" value="AAH63414.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY229892">
<property type="protein sequence ID" value="AAP69563.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3495.1">
<molecule id="P16234-1"/>
</dbReference>
<dbReference type="PIR" id="A40162">
<property type="entry name" value="PFHUGA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001334758.1">
<molecule id="P16234-1"/>
<property type="nucleotide sequence ID" value="NM_001347829.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006197.1">
<molecule id="P16234-1"/>
<property type="nucleotide sequence ID" value="NM_006206.5"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005265800.1">
<molecule id="P16234-1"/>
<property type="nucleotide sequence ID" value="XM_005265743.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.74615"/>
<dbReference type="PDB" id="1GQ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
</dbReference>
<dbReference type="PDB" id="5GRN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A=550-973"/>
</dbReference>
<dbReference type="PDB" id="5K5X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.17"/>
<property type="chains" value="A=550-973"/>
</dbReference>
<dbReference type="PDBsum" id="1GQ5"/>
<dbReference type="PDBsum" id="5GRN"/>
<dbReference type="PDBsum" id="5K5X"/>
<dbReference type="ProteinModelPortal" id="P16234"/>
<dbReference type="SMR" id="P16234"/>
<dbReference type="BioGrid" id="111182">
<property type="interactions" value="60"/>
</dbReference>
<dbReference type="CORUM" id="P16234"/>
<dbReference type="DIP" id="DIP-5736N"/>
<dbReference type="IntAct" id="P16234">
<property type="interactions" value="39"/>
</dbReference>
<dbReference type="MINT" id="MINT-4529366"/>
<dbReference type="STRING" id="9606.ENSP00000257290"/>
<dbReference type="BindingDB" id="P16234"/>
<dbReference type="ChEMBL" id="CHEMBL2007"/>
<dbReference type="DrugBank" id="DB00102">
<property type="generic name" value="Becaplermin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00619">
<property type="generic name" value="Imatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05216">
<property type="generic name" value="MP470"/>
</dbReference>
<dbReference type="DrugBank" id="DB06043">
<property type="generic name" value="Olaratumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB06589">
<property type="generic name" value="Pazopanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08901">
<property type="generic name" value="Ponatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01268">
<property type="generic name" value="Sunitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05146">
<property type="generic name" value="XL820"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1803"/>
<dbReference type="iPTMnet" id="P16234"/>
<dbReference type="PhosphoSitePlus" id="P16234"/>
<dbReference type="BioMuta" id="PDGFRA"/>
<dbReference type="DMDM" id="129892"/>
<dbReference type="MaxQB" id="P16234"/>
<dbReference type="PaxDb" id="P16234"/>
<dbReference type="PeptideAtlas" id="P16234"/>
<dbReference type="PRIDE" id="P16234"/>
<dbReference type="DNASU" id="5156"/>
<dbReference type="Ensembl" id="ENST00000257290">
<molecule id="P16234-1"/>
<property type="protein sequence ID" value="ENSP00000257290"/>
<property type="gene ID" value="ENSG00000134853"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000508170">
<molecule id="P16234-2"/>
<property type="protein sequence ID" value="ENSP00000425648"/>
<property type="gene ID" value="ENSG00000134853"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000509490">
<molecule id="P16234-3"/>
<property type="protein sequence ID" value="ENSP00000424218"/>
<property type="gene ID" value="ENSG00000134853"/>
</dbReference>
<dbReference type="GeneID" id="5156"/>
<dbReference type="KEGG" id="hsa:5156"/>
<dbReference type="UCSC" id="uc003hal.4">
<molecule id="P16234-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5156"/>
<dbReference type="DisGeNET" id="5156"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000134853.11"/>
<dbReference type="GeneCards" id="PDGFRA"/>
<dbReference type="HGNC" id="HGNC:8803">
<property type="gene designation" value="PDGFRA"/>
</dbReference>
<dbReference type="HPA" id="CAB018143"/>
<dbReference type="HPA" id="HPA004947"/>
<dbReference type="MalaCards" id="PDGFRA"/>
<dbReference type="MIM" id="173490">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="606764">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607685">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P16234"/>
<dbReference type="OpenTargets" id="ENSG00000134853"/>
<dbReference type="Orphanet" id="44890">
<property type="disease" value="Gastrointestinal stromal tumor"/>
</dbReference>
<dbReference type="Orphanet" id="168947">
<property type="disease" value="Myeloid neoplasm associated with PDGFRA rearrangement"/>
</dbReference>
<dbReference type="Orphanet" id="99860">
<property type="disease" value="Precursor B-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="314950">
<property type="disease" value="Primary hypereosinophilic syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33147"/>
<dbReference type="eggNOG" id="KOG0200">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118923"/>
<dbReference type="HOGENOM" id="HOG000112009"/>
<dbReference type="HOVERGEN" id="HBG004335"/>
<dbReference type="InParanoid" id="P16234"/>
<dbReference type="KO" id="K04363"/>
<dbReference type="OMA" id="CKDIKKC"/>
<dbReference type="OrthoDB" id="EOG091G01TL"/>
<dbReference type="PhylomeDB" id="P16234"/>
<dbReference type="TreeFam" id="TF325768"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186763">
<property type="pathway name" value="Downstream signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186797">
<property type="pathway name" value="Signaling by PDGF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P16234"/>
<dbReference type="SIGNOR" id="P16234"/>
<dbReference type="ChiTaRS" id="PDGFRA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P16234"/>
<dbReference type="GeneWiki" id="PDGFRA"/>
<dbReference type="GenomeRNAi" id="5156"/>
<dbReference type="PRO" id="PR:P16234"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000134853"/>
<dbReference type="CleanEx" id="HS_PDGFRA"/>
<dbReference type="ExpressionAtlas" id="P16234">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P16234">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030054">
<property type="term" value="C:cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031226">
<property type="term" value="C:intrinsic component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005018">
<property type="term" value="F:platelet-derived growth factor alpha-receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048407">
<property type="term" value="F:platelet-derived growth factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005161">
<property type="term" value="F:platelet-derived growth factor receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038085">
<property type="term" value="F:vascular endothelial growth factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005021">
<property type="term" value="F:vascular endothelial growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0055003">
<property type="term" value="P:cardiac myofibril assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001775">
<property type="term" value="P:cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060326">
<property type="term" value="P:cell chemotaxis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034614">
<property type="term" value="P:cellular response to reactive oxygen species"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0048701">
<property type="term" value="P:embryonic cranial skeleton morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048557">
<property type="term" value="P:embryonic digestive tract morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048704">
<property type="term" value="P:embryonic skeletal system morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001553">
<property type="term" value="P:luteinization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0072277">
<property type="term" value="P:metanephric glomerular capillary formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010544">
<property type="term" value="P:negative regulation of platelet activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000587">
<property type="term" value="P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070527">
<property type="term" value="P:platelet aggregation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048008">
<property type="term" value="P:platelet-derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035790">
<property type="term" value="P:platelet-derived growth factor receptor-alpha signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038091">
<property type="term" value="P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007204">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045740">
<property type="term" value="P:positive regulation of DNA replication"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048146">
<property type="term" value="P:positive regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010863">
<property type="term" value="P:positive regulation of phospholipase C activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000249">
<property type="term" value="P:regulation of actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050920">
<property type="term" value="P:regulation of chemotaxis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000739">
<property type="term" value="P:regulation of mesenchymal stem cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061298">
<property type="term" value="P:retina vasculature development in camera-type eye"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="6"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR013098">
<property type="entry name" value="Ig_I-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR027290">
<property type="entry name" value="PDGFRA"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001824">
<property type="entry name" value="Tyr_kinase_rcpt_3_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF07679">
<property type="entry name" value="I-set"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF500950">
<property type="entry name" value="Alpha-PDGF_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00240">
<property type="entry name" value="RECEPTOR_TYR_KIN_III"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0145">Chemotaxis</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide">
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="chain" description="Platelet-derived growth factor receptor alpha" id="PRO_0000016760">
<location>
<begin position="24"/>
<end position="1089"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="24"/>
<end position="528"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="529"/>
<end position="549"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="550"/>
<end position="1089"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="24"/>
<end position="113"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="117"/>
<end position="201"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="202"/>
<end position="306"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 4">
<location>
<begin position="319"/>
<end position="410"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 5">
<location>
<begin position="414"/>
<end position="517"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="6">
<location>
<begin position="593"/>
<end position="954"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="6">
<location>
<begin position="599"/>
<end position="607"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="1041"/>
<end position="1087"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="6 7">
<location>
<position position="818"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="6">
<location>
<position position="627"/>
</location>
</feature>
<feature type="site" description="Breakpoint for interstitial deletion to form the FIP1L1-PDGFRA fusion protein">
<location>
<begin position="578"/>
<end position="579"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="9">
<location>
<position position="572"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="9">
<location>
<position position="574"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="11 40">
<location>
<position position="720"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="20">
<location>
<position position="731"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="20">
<location>
<position position="742"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="24">
<location>
<position position="754"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="8">
<location>
<position position="762"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37">
<location>
<position position="768"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="3">
<location>
<position position="849"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="33">
<location>
<position position="988"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="33">
<location>
<position position="1018"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="42"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="76"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="103"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="179"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="353"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="359"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="458"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="468"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="49"/>
<end position="100"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="150"/>
<end position="189"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="235"/>
<end position="290"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="435"/>
<end position="501"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_007833" evidence="41">
<original>ATSELDLEM</original>
<variation>GTCIISFLL</variation>
<location>
<begin position="210"/>
<end position="218"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_007834" evidence="41">
<location>
<begin position="219"/>
<end position="1089"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_042015" evidence="41">
<original>YVILSFENNGDYMDMKQADTTQYV</original>
<variation>SGQGCLSSGTLQELSVDLQARGPC</variation>
<location>
<begin position="720"/>
<end position="743"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_042016" evidence="41">
<location>
<begin position="744"/>
<end position="1089"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs36035373." id="VAR_042032" evidence="23">
<original>G</original>
<variation>D</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55865821." id="VAR_042033" evidence="23">
<original>G</original>
<variation>D</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35597368." id="VAR_034378" evidence="17 18 23">
<original>S</original>
<variation>P</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="sequence variant" description="In a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation." id="VAR_066460" evidence="27">
<original>R</original>
<variation>G</variation>
<location>
<position position="481"/>
</location>
</feature>
<feature type="sequence variant" description="In a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation." id="VAR_066461" evidence="27">
<original>L</original>
<variation>P</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="sequence variant" description="In a GIST sample; constitutively activated kinase; dbSNP:rs121908586." id="VAR_066462" evidence="14 19">
<original>V</original>
<variation>D</variation>
<location>
<position position="561"/>
</location>
</feature>
<feature type="sequence variant" description="In a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation." id="VAR_066463" evidence="27">
<original>I</original>
<variation>M</variation>
<location>
<position position="562"/>
</location>
</feature>
<feature type="sequence variant" description="In a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation." id="VAR_066464" evidence="27">
<original>H</original>
<variation>R</variation>
<location>
<position position="570"/>
</location>
</feature>
<feature type="sequence variant" description="In a hypereosinophilic syndrome sample; constitutively activated kinase." id="VAR_066465" evidence="27">
<original>H</original>
<variation>Q</variation>
<location>
<position position="650"/>
</location>
</feature>
<feature type="sequence variant" description="In GIST sample; constitutively activated kinase." id="VAR_066466" evidence="19">
<original>N</original>
<variation>K</variation>
<location>
<position position="659"/>
</location>
</feature>
<feature type="sequence variant" description="In a hypereosinophilic syndrome sample; constitutively activated kinase." id="VAR_066467" evidence="27">
<original>N</original>
<variation>S</variation>
<location>
<position position="659"/>
</location>
</feature>
<feature type="sequence variant" description="In a hypereosinophilic syndrome sample; does not lead to constitutive kinase activation." id="VAR_066468" evidence="27">
<original>L</original>
<variation>P</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="sequence variant" description="In a hypereosinophilic syndrome sample; constitutively activated kinase." id="VAR_066469" evidence="27">
<original>R</original>
<variation>G</variation>
<location>
<position position="748"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34392012." id="VAR_042034" evidence="23">
<original>R</original>
<variation>C</variation>
<location>
<position position="764"/>
</location>
</feature>
<feature type="sequence variant" description="In a glioblastoma multiforme sample; somatic mutation." id="VAR_042035" evidence="23">
<original>G</original>
<variation>R</variation>
<location>
<position position="829"/>
</location>
</feature>
<feature type="sequence variant" description="In a GIST sample; constitutively activated kinase." id="VAR_066470" evidence="14 19">
<location>
<begin position="842"/>
<end position="845"/>
</location>
</feature>
<feature type="sequence variant" description="In a GIST sample; imatinib resistant, constitutively activated kinase; dbSNP:rs121908585." id="VAR_066471" evidence="14 19 26">
<original>D</original>
<variation>V</variation>
<location>
<position position="842"/>
</location>
</feature>
<feature type="sequence variant" description="In a GIST sample; imatinib sensitive, constitutively activated kinase; dbSNP:rs121913265." id="VAR_066472" evidence="19">
<original>D</original>
<variation>Y</variation>
<location>
<position position="842"/>
</location>
</feature>
<feature type="sequence variant" description="In a GIST sample; constitutively activated kinase." id="VAR_066473" evidence="14 19">
<location>
<begin position="845"/>
<end position="848"/>
</location>
</feature>
<feature type="sequence variant" description="In GIST." id="VAR_066474" evidence="19">
<original>Y</original>
<variation>C</variation>
<location>
<position position="849"/>
</location>
</feature>
<feature type="sequence variant" description="In a hypereosinophilic syndrome sample; constitutively activated kinase." id="VAR_066475" evidence="27">
<original>Y</original>
<variation>S</variation>
<location>
<position position="849"/>
</location>
</feature>
<feature type="sequence variant" description="In a metastatic melanoma sample; somatic mutation; dbSNP:rs779173667." id="VAR_042036" evidence="23">
<original>E</original>
<variation>K</variation>
<location>
<position position="996"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung neuroendocrine carcinoma sample; somatic mutation; dbSNP:rs376544204." id="VAR_042037" evidence="23">
<original>D</original>
<variation>N</variation>
<location>
<position position="1071"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SRC-family members and impairs internalization of the activated receptor; when associated with F-574." evidence="9 16">
<original>Y</original>
<variation>F</variation>
<location>
<position position="572"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SRC-family members and impairs internalization of the activated receptor; when associated with F-572." evidence="9 16">
<original>Y</original>
<variation>F</variation>
<location>
<position position="574"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced interaction with PTPN11 and GRB2." evidence="40">
<original>Y</original>
<variation>F</variation>
<location>
<position position="720"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on autophosphorylation and phosphorylation of PLCG1. Abolishes activation of phosphatidylinositol 3-kinase." evidence="20">
<original>Y</original>
<variation>F</variation>
<location>
<position position="731"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on autophosphorylation and phosphorylation of PLCG1. Abolishes activation of phosphatidylinositol 3-kinase." evidence="20">
<original>Y</original>
<variation>F</variation>
<location>
<position position="742"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CRK." evidence="8">
<original>Y</original>
<variation>F</variation>
<location>
<position position="762"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="560"/>
<end position="565"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="572"/>
<end position="574"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="577"/>
<end position="579"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="584"/>
<end position="586"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="590"/>
<end position="592"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="593"/>
<end position="601"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="603"/>
<end position="614"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="616"/>
<end position="618"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="620"/>
<end position="629"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="635"/>
<end position="651"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="660"/>
<end position="664"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="666"/>
<end position="669"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="671"/>
<end position="675"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="682"/>
<end position="688"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="774"/>
<end position="776"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="778"/>
<end position="781"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="792"/>
<end position="811"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="821"/>
<end position="823"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="824"/>
<end position="827"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="828"/>
<end position="830"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="831"/>
<end position="834"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="838"/>
<end position="840"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="843"/>
<end position="845"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="849"/>
<end position="851"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="853"/>
<end position="857"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="859"/>
<end position="861"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="864"/>
<end position="869"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="874"/>
<end position="889"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="903"/>
<end position="910"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="923"/>
<end position="932"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="937"/>
<end position="939"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="943"/>
<end position="953"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="956"/>
<end position="971"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5GRN"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5K5X"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10733900"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10734113"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10947961"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11095946"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11297552"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11882663"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12522257"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12808148"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14644164"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15928335"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1646396"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1709159"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17141222"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17604334"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20660204"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20972453"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21224473"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21596750"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2173144"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2536956"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2544881"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2554309"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7535778"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7679113"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7896447"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8188664"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8617789"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8760137"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8940081"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8943348"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000305"/>
<evidence key="43" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21596750"/>
</source>
</evidence>
<sequence length="1089" mass="122670" checksum="5E3FB9940ACD1BE8" modified="1990-04-01" version="1" precursor="true">
MGTSHPAFLVLGCLLTGLSLILCQLSLPSILPNENEKVVQLNSSFSLRCFGESEVSWQYP
MSEEESSDVEIRNEENNSGLFVTVLEVSSASAAHTGLYTCYYNHTQTEENELEGRHIYIY
VPDPDVAFVPLGMTDYLVIVEDDDSAIIPCRTTDPETPVTLHNSEGVVPASYDSRQGFNG
TFTVGPYICEATVKGKKFQTIPFNVYALKATSELDLEMEALKTVYKSGETIVVTCAVFNN
EVVDLQWTYPGEVKGKGITMLEEIKVPSIKLVYTLTVPEATVKDSGDYECAARQATREVK
EMKKVTISVHEKGFIEIKPTFSQLEAVNLHEVKHFVVEVRAYPPPRISWLKNNLTLIENL
TEITTDVEKIQEIRYRSKLKLIRAKEEDSGHYTIVAQNEDAVKSYTFELLTQVPSSILDL
VDDHHGSTGGQTVRCTAEGTPLPDIEWMICKDIKKCNNETSWTILANNVSNIITEIHSRD
RSTVEGRVTFAKVEETIAVRCLAKNLLGAENRELKLVAPTLRSELTVAAAVLVLLVIVII
SLIVLVVIWKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRVLG
SGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNL
LGACTKSGPIYIITEYCFYGDLVNYLHKNRDSFLSHHPEKPKKELDIFGLNPADESTRSY
VILSFENNGDYMDMKQADTTQYVPMLERKEVSKYSDIQRSLYDRPASYKKKSMLDSEVKN
LLSDDNSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA
RDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMM
VDSTFYNKIKSGYRMAKPDHATSEVYEIMVKCWNSEPEKRPSFYHLSEIVENLLPGQYKK
SYEKIHLDFLKSDHPAVARMRVDSDNAYIGVTYKNEEDKLKDWEGGLDEQRLSADSGYII
PLPDIDPVPEEEDLGKRNRHSSQTSEESAIETGSSSSTFIKREDETIEDIDMMDDIGIDS
SDLVEDSFL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>